Nnamdi Njoku - 15 Mar 2026 Form 4 Insider Report for OMNICELL, INC. (OMCL)

Role
EVP, Chief Operating Officer
Signature
/s/ Eric Lehmann, Attorney-in-Fact for Nnamdi Njoku
Issuer symbol
OMCL
Transactions as of
15 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 16:05:15 UTC
Previous filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Njoku Nnamdi EVP, Chief Operating Officer 4220 NORTH FREEWAY, FORT WORTH /s/ Eric Lehmann, Attorney-in-Fact for Nnamdi Njoku 17 Mar 2026 0002034946

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMCL Common Stock Award +37,409 +43% $0.000000* 123,695 15 Mar 2026 Direct F1
transaction OMCL Common Stock Tax liability -8,456 -6.8% $34.40* 115,239 15 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 37,409 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).
F2 Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.